Welcome to Medical News Today

Healthline Media, Inc. would like to process and share personal data (e.g., mobile ad id) and data about your use of our site (e.g., content interests) with our third party partners (see a current list) using cookies and similar automatic collection tools in order to a) personalize content and/or offers on our site or other sites, b) communicate with you upon request, and/or c) for additional reasons upon notice and, when applicable, with your consent.

Healthline Media, Inc. is based in and operates this site from the United States. Any data you provide will be primarily stored and processed in the United States, pursuant to the laws of the United States, which may provide lesser privacy protections than European Economic Area countries.

By clicking “accept” below, you acknowledge and grant your consent for these activities unless and until you withdraw your consent using our rights request form. Learn more in our Privacy Policy.

Please accept our privacy terms

We use cookies and similar technologies to improve your browsing experience, personalize content and offers, show targeted ads, analyze traffic, and better understand you. We may share your information with third-party partners for marketing purposes. To learn more and make choices about data use, visit our Advertising Policy and Privacy Policy. By clicking “Accept and Continue” below, (1) you consent to these activities unless and until you withdraw your consent using our rights request form, and (2) you consent to allow your data to be transferred, processed, and stored in the United States.

Inhaled blood pressure drug could prevent panic attacks

Amiloride, a drug that's used to treat hypertension, successfully relieves signs of anxiety and panic in a preclinical study. The findings are underpinned and strengthened by epigenetic changes caused by anxiety and panic disorder.

An inhaled version of amiloride may relieve hyperventilation, which often accompanies panic attacks.

Adverse events in one's childhood, such as a death in the family or separation from one's parents, can have not only a profound psychological effect, but also molecular and genetic ones.

Using existing knowledge on the genetic impact of childhood adversity and the risk of developing anxiety disorders into adulthood, researchers from the Centre for Addiction and Mental Health (CAMH) in Toronto, Canada, investigated whether an existing drug can instantly alleviate the symptoms of panic attacks by acting on the molecular changes that are brought about by childhood adversity.

Dr. Marco Battaglia, associate chief of child and youth psychiatry in the Campbell Family Mental Health Research Institute at CAMH, is the lead author of the new study, which has now been published in the Journal of Psychopharmacology.

Childhood trauma, epigenetics, and anxiety

As Dr. Battaglia and his colleagues explain in their paper, experiments in mice have revealed that repeatedly separating pups from their mothers causes epigenetic modifications.

Epigenetics refers to modifications in the DNA that do not change the DNA's sequence but can affect whether some genes are switched on or off.

Specifically, in this new study, the scientists build on previous research in mice that has suggested that childhood trauma causes changes in the acid-sensing-ion-channel-1 gene, heightened pain sensitivity, and hypersensitivity to carbon dioxide in the air.

As the researchers explain, these physiological changes (such as carbon dioxide hypersensitivity) may lead to physical symptoms, such as difficulty breathing and hyperventilation, which are markers of panic attacks.

Based on this knowledge, the team hypothesized that a drug that can inhibit acid-sensing ion channels can also reduce pain sensitivity and hypersensitivity to carbon dioxide.

So, Dr. Battaglia and his team assessed the effects of the acid-sensing ion channel inhibitor "amiloride," a drug commonly used to treat hypertension.

Inhaled amiloride may treat panic disorder

To circumvent the issue of the brain-blood barrier, the scientists administered the drug to mice via inhalation. This enabled the drug to reach the rodents' brains immediately.

In its inhaled form, one dose of amiloride improved the respiratory signs of anxiety and pain sensitivity in the rodents.

"Inhaled amiloride may prove to have benefits for panic disorder, which is typically characterized by spells of shortness of breath and fear, when people feel anxiety levels rising."

Such hopeful preclinical results have prompted them to replicate the findings in a clinical setting. Next, Dr. Battaglia and team are planning to see whether the drug relieves anxiety symptoms in humans.

2018 Healthline Media UK Ltd. All rights reserved. MNT is the registered trade mark of Healthline Media. Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a healthcare professional.